Private-credit stocks have been weighed down by worries over their loans to software firms. Investors are anxious to learn the latest on their loan portfolios.
2 minute read
Musk’s lawyers argued that a 55-year old securities law violates the right to free speech.
1 minute read
Shares of Sagimet Biosciences were up as much as 12% after encouraging clinical trial results for its acne treatment.
3 minute read
After ending Friday at $83,817 Bitcoin fell 7% to $78,092 by Saturday evening.
1 minute read
Chairman Michael Selig said that the CFTC would rectify the confusion left by its failure to issue clear rules for prediction markets, which the agency calls “event contracts.”
2 minute read
It’s unclear how quickly lawmakers in the House of Representatives will be able to vote on the bill.
4 minute read
Recent securities filings show that investors may be calming down.
3 minute read
Earnings for 2025 were the best ever and capital inflows were “stunning,” said Blackstone CEO Stephen Schwartzman.
3 minute read
Travelers, Chubb, Allstate, and Hartford are all likely to take meaningful losses from the weekend storm, one analyst predicts.
2 minute read
Blackstone, KKR, Apollo Global Management and Brookfield are getting ready to report quarterly earnings.
4 minute read
The industrial real estate sector has outperformed, but may face tougher going now.
3 minute read
The investment bank argues that fundamentals haven’t changed much even as sentiment swung sharply on credit concerns.
2 minute read
Over 93% of SEC cases filed against public companies in the agency’s fiscal year had been initiated under the prior administration, concludes a study.
3 minute read
Lawyers for the Tesla CEO made the argument in federal court. He is fighting allegations he filed a late stock-ownership notice when buying shares of Twitter in 2022.
2 minute read
Amgen reported early Phase 2 data suggesting patients kept weight off with less frequent dosing, a potential differentiator from Eli Lilly and Novo Nordisk.
2 minute read
Public fear over the sector’s loans is overblown, say industry analysts, but declining interest rates will continue to weigh on BDC stocks.
2 minute read
Pill versions of the successful GLP1 drugs from Novo Nordisk and Eli Lilly will likely be on the market in 2026’s first half.
3 minute read
Elliott faces court and regulatory challenges before taking over Citgo, plus other refiners will compete with Citgo to refine Venezuelan crude.
2 minute read
The Wall Street trade group Sifma gathered private fund and retirement managers to discuss how such assets could meet the liquidity needs of retirement plan.
3 minute read
of 117 pages